Gainers
- Vapotherm VAPO stock increased by 10.5% to $0.42 during Monday's after-market session. The company's market cap stands at $19.4 million.
- IN8bio INAB shares increased by 9.32% to $1.29. The market value of their outstanding shares is at $38.3 million.
- NeuBase Therapeutics NBSE stock increased by 8.63% to $1.51. The company's market cap stands at $2.8 million.
- Emergent BioSolutions EBS shares rose 8.3% to $7.45. Today's trading volume for this security ended up closing at 500.8K shares, which is 36.2 percent of its average volume over the last 100 days. The market value of their outstanding shares is at $375.9 million.
- Know Labs KNW shares increased by 7.05% to $0.92. The market value of their outstanding shares is at $44.6 million.
- Matinas BioPharma Hldgs MTNB stock increased by 5.42% to $0.37. The company's market cap stands at $81.2 million.
Losers
- Acer Therapeutics ACER shares fell 8.1% to $0.8 during Monday's after-market session. The market value of their outstanding shares is at $19.6 million.
- Tarsus Pharmaceuticals TARS stock decreased by 6.87% to $20.5. This security traded at a volume of 97.5K shares come close, making up 33.0% of its average volume over the last 100 days. The company's market cap stands at $549.4 million.
- Mallinckrodt MNK shares decreased by 5.56% to $1.53. At the close, Mallinckrodt's trading volume reached 524.4K shares. This is 13.3% of its average volume over the last 100 days. The market value of their outstanding shares is at $20.1 million.
- TFF Pharmaceuticals TFFP stock declined by 5.48% to $0.4. The market value of their outstanding shares is at $14.5 million.
- AlloVir ALVR shares fell 5.17% to $3.12. The company's market cap stands at $354.3 million.
- Vaccinex VCNX shares declined by 5.0% to $0.28. The company's market cap stands at $18.0 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in